AJP - Lung AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (June 20, 2008). doi:10.1152/ajplung.00392.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/3/L412    most recent
00392.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thatcher, T. H
Right arrow Articles by Sime, P. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thatcher, T. H
Right arrow Articles by Sime, P. J
Submitted on September 19, 2007
Accepted on June 19, 2008

High Dose but not Low Dose Mainstream Cigarette Smoke Suppresses Allergic Airway Inflammation by Inhibiting T Cell Function

Thomas H Thatcher1, Randi P. Benson2, Richard P Phipps3, and Patricia J Sime4*

1 Pulmonary and Critical Care Medicine, University of Rochester, Rochester, New York, United States
2 Environmental Medicine, University of Rochester, Rochester, New York, United States
3 Dept. of Environmental Medicine and the Lung Biology and Disease Program, University of Rochester, Rochester, New York, United States
4 Pulmonary and Critical Care Medicine, Box 692, University of Rochester Medical Center, Rochester, New York, United States

* To whom correspondence should be addressed. E-mail: patricia_sime{at}urmc.rochester.edu.

Epidemiological studies have identified childhood exposure to environmental tobacco smoke as a significant risk factor for the onset and exacerbation of asthma, but studies of smoking in adults are less conclusive, and mainstream cigarette smoke (MCS) has been reported to both enhance and attenuate allergic airway inflammation in animal models. We sensitized mice to ovalbumin (OVA), and exposed them to MCS in a well-characterized exposure system. Exposure to MCS (600 mg/m3 total suspended particulates, TSP) for 2 hours per day suppresses the allergic airway response, with reductions in eosinophilia, tissue inflammation, goblet cell metaplasia, IL-4 and IL-5 in BALF, and OVA-specific antibodies. Suppression is associated with a loss of antigen-specific proliferation and cytokine production by T cells. However, exposure to a lower dose of MCS (77 mg/m3 TSP) had no effect on the number of BAL eosinophils or OVA-specific antibodies. This is the first report to demonstrate, using identical smoking methodologies, that MCS inhibits immune responses in a dose-dependent manner, and may explain the observation that, although smoking provokes a systemic inflammatory response, it also inhibits T cell-mediated responses involved in a number of diseases.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.